Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study.
Tilly H, Morschhauser F, Casasnovas O, Molina TJ, Feugier P, Gouill SL, Haioun C, Tournilhac O, Bouabdallah R, Gabarre J, Lamy T, Cabeçadas J, Becker S, Jardin F, Mounier N, Salles G; Lymphoma Study Association. Tilly H, et al. Lancet Haematol. 2018 Sep;5(9):e403-e410. doi: 10.1016/S2352-3026(18)30131-5. Lancet Haematol. 2018. PMID: 30172345 Clinical Trial.
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
Haioun C, Lepage E, Gisselbrecht C, Coiffier B, Bosly A, Tilly H, Morel P, Nouvel C, Herbrecht R, D'Agay MF, et al. Haioun C, et al. Among authors: tilly h. J Clin Oncol. 1994 Dec;12(12):2543-51. doi: 10.1200/JCO.1994.12.12.2543. J Clin Oncol. 1994. PMID: 7527453 Clinical Trial.
A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.
Dombret H, Chastang C, Fenaux P, Reiffers J, Bordessoule D, Bouabdallah R, Mandelli F, Ferrant A, Auzanneau G, Tilly H, et al. Dombret H, et al. Among authors: tilly h. N Engl J Med. 1995 Jun 22;332(25):1678-83. doi: 10.1056/NEJM199506223322504. N Engl J Med. 1995. PMID: 7539109 Free article. Clinical Trial.
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
Lepage E, Gisselbrecht C, Haioun C, Sebban C, Tilly H, Bosly A, Morel P, Herbrecht R, Reyes F, Coiffier B. Lepage E, et al. Among authors: tilly h. Ann Oncol. 1993 Sep;4(8):651-6. doi: 10.1093/oxfordjournals.annonc.a058619. Ann Oncol. 1993. PMID: 7694634 Free article. Clinical Trial.
Interleukin-2 treatment in lymphoma: a phase II multicenter study.
Gisselbrecht C, Maraninchi D, Pico JL, Milpied N, Coiffier B, Divine M, Tiberghien P, Bosly A, Tilly H, Boulat O, et al. Gisselbrecht C, et al. Among authors: tilly h. Blood. 1994 Apr 15;83(8):2081-5. Blood. 1994. PMID: 8161779 Free article. Clinical Trial.
473 results